StonvexLoading…
StonvexStonvexStonvexCore line items from ARHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $372.05M | $314.28M | $1.38B | $1.01B | $669.81M |
Operating Income | Not available | $2.14M | $88.89M | $68.62M | $52.19M |
Net Income | Not available | $2.22M | $67.26M | $52.17M | $39.95M |
EPS (Diluted) | $0.19 | $0.02 | $0.48 | $0.37 | $0.28 |
Total Assets | Not available | $1.38B | $1.39B | $1.38B | $1.32B |
Total Liabilities | Not available | $1.00B | $976.52M | $978.22M | $932.76M |
Cash & Equivalents | Not available | $177.11M | $253.36M | $262.23M | $234.80M |
Free Cash Flow OCF − CapEx | Not available | $-26.58M | $58.98M | $67.79M | $39.81M |
Shares Outstanding | Not available | 141.74M | 141.41M | 141.31M | 141.13M |